InflaRx (IFRX) Enterprise Value Growth (1y) (2017 - 2026)
InflaRx (IFRX) Enterprise Value Growth (1y) (2017 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
723,416.35 Bn |
723,416.32 Bn |
- |
| 2 |
Belite Bio |
57,340.00 Bn |
57,340.00 Bn |
- |
| 3 |
Quantum Biopharma |
19,125.08 Bn |
19,125.08 Bn |
- |
| 4 |
Legend Biotech |
3,262.00 Bn |
3,261.71 Bn |
242.10 Mn |
| 5 |
Akari Therapeutics |
1,789.67 Bn |
1,789.67 Bn |
- |
| 6 |
Evaxion A |
1,480.39 Bn |
1,480.37 Bn |
- |
| 7 |
Psyence Biomedical |
241.78 Bn |
241.78 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
113.54 Bn |
106.29 Bn |
2.59 Bn |
| 9 |
Abivax |
94.26 Bn |
94.26 Bn |
- |
| 10 |
InflaRx |
764.68 Mn |
764.68 Mn |
10,877.40 |
| Date | Value |
|---|
| Mar 31, 2026 |
-74,723,111.71% |
| Dec 31, 2025 |
-85,602,086.34% |
| Sep 30, 2025 |
46.24% |
| Jun 30, 2025 |
80.08% |
| Mar 31, 2025 |
50.02% |
| Dec 31, 2024 |
57.39% |
| Sep 30, 2024 |
88.09% |
| Jun 30, 2024 |
27.72% |
| Mar 31, 2024 |
8.34% |
| Dec 31, 2023 |
-17.42% |
| Sep 30, 2023 |
-14.57% |
| Jun 30, 2023 |
7.05% |
| Mar 31, 2023 |
-187.98% |
| Dec 31, 2022 |
13.31% |
| Sep 30, 2022 |
100.00% |
| Jun 30, 2022 |
-251.62% |
| Mar 31, 2022 |
5.95% |
| Dec 31, 2021 |
-203.40% |
| Sep 30, 2021 |
-47,704.38% |
| Jun 30, 2021 |
99.95% |
